source,column_name,column_value,value_count
Vaccines,Developer,"FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo",6
Vaccines,Developer,"National Research Centre, Egypt",4
Vaccines,Developer,Selcuk University,2
Vaccines,Developer,Max-Planck-institute of Colloids and Interfaces,2
Vaccines,Developer,Intravacc/Epivax,2
Vaccines,Developer,"IDIBAPS-Hospital Clinic, Spain",2
Vaccines,Developer,Cadila Healthcare Limited,2
Vaccines,Developer,"Research Institute for Biological Safety Problems, Rep of Kazakhstan",2
Vaccines,Developer,University of Manitoba,2
Vaccines,Developer,Farmacologicos Veterinarios SAC (FARVET SAC) / Universidad Peruana Cayetano Heredia (UPCH),2
Vaccines,Developer,"Centro Nacional Biotecnologia (CNB-CSIC), Spain",2
Vaccines,Developer,Erciyes University,2
Vaccines,Developer,Fudan University/ Shanghai JiaoTong University/RNACure Biopharma,2
Vaccines,Developer,IrsiCaixa AIDS Research/IRTA-CReSA/Barcelona Supercomputing Centre/Grifols,1
Vaccines,Developer,VBI Vaccines Inc.,1
Vaccines,Developer,Baiya Phytopharm/ Chula Vaccine Research Center,1
Vaccines,Developer,"MOGAM Institute for Biomedical Research, GC Pharma",1
Vaccines,Developer,Greffex,1
Vaccines,Developer,Institute Pasteur/Themis/Univ. of Pittsburg CVR/Merck Sharp & Dohme,1
Vaccines,Developer,BIOCAD,1
Vaccines,Developer,Heat Biologics/Univ. Of Miami,1
Vaccines,Developer,Osaka University/ AnGes/ Takara Bio,1
Vaccines,Developer,ImmunoPrecise/LiteVax BV,1
Vaccines,Developer,"Instituto Finlay de Vacunas, Cuba",1
Vaccines,Developer,Janssen Pharmaceutical Companies,1
Vaccines,Developer,Biological E Ltd,1
Vaccines,Developer,"Applied Biotechnology Institute, Inc.",1
Vaccines,Developer,Mehmet Ali Aydinlar University / Acibadem Labmed Health Services A.S.,1
Vaccines,Developer,Chula Vaccine Research Center,1
Vaccines,Developer,"Institute of Medical Biology, Chinese Academy of Medical Sciences",1
Vaccines,Developer,Tonix Pharma/Southern Research,1
Vaccines,Developer,ARTES Biotechnology,1
Vaccines,Developer,Flow Pharma Inc,1
Vaccines,Developer,Univ. of Sao Paulo,1
Vaccines,Developer,Symvivo,1
Vaccines,Developer,"RNAimmune, Inc.",1
Vaccines,Developer,acc/ Wageninger Bioveterinary Research/Utrecht Univ.,1
Vaccines,Developer,"Helix Biogen Consult, Ogbomoso & Trinity Immonoefficient Laboratory, Ogbomoso, Oyo State, Nigeria.",1
Vaccines,Developer,Baylor College of Medicine,1
Vaccines,Developer,Valneva/Dynavax,1
Vaccines,Developer,ReiThera/LEUKOCARE/Univercells,1
Vaccines,Developer,BioNTech/Fosun Pharma/Pfizer,1
Vaccines,Developer,Bharat Biotech/Thomas Jefferson University,1
Vaccines,Developer,Ankara University,1
Vaccines,Developer,eTheRNA,1
Vaccines,Developer,Indian Immunologicals Ltd/Griffith University,1
Vaccines,Developer,Gennova,1
Vaccines,Developer,WRAIR/USAMRIID,1
Vaccines,Developer,Gamaleya Research Institute,1
Vaccines,Developer,"Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences",1
Vaccines,Developer,Vabiotech,1
Vaccines,Developer,Bogazici University,1
Vaccines,Developer,Osaka University/ BIKEN/ National Institutes of Biomedical Innovation,1
Vaccines,Developer,MIGAL Galilee Research Institute,1
Vaccines,Developer,Sanofi Pasteur/GSK,1
Vaccines,Developer,University of Georgia/University of lowa,1
Vaccines,Developer,Middle East Technical University,1
Vaccines,Developer,BiOCAD and IEM,1
Vaccines,Developer,KM Biologics,1
Vaccines,Developer,Karolinska Institute / Cobra Biologics (OPENCORONA Project),1
Vaccines,Developer,Generex/EpiVax,1
Vaccines,Developer,"National Institute of Infectious Disease, Japan/Shionogi/UMN Pharma",1
Vaccines,Developer,Mediphage Bioceuticals/University of Waterloo,1
Vaccines,Developer,ID Pharma,1
Vaccines,Developer,Mahidol University/ The Government Pharmaceutical Organization (GPO)/Siriraj Hospital,1
Vaccines,Developer,EpiVax/Univ. of Georgia,1
Vaccines,Developer,Sinovac/Dynavax,1
Vaccines,Developer,University of Virginia,1
Vaccines,Developer,Curevac,1
Vaccines,Developer,Mynvax,1
Vaccines,Developer,AdaptVac (PREVENT-nCoV consortium),1
Vaccines,Developer,"Immunomic Therapeutics, Inc./EpiVax, Inc./Pharmalet",1
Vaccines,Developer,OSIVAX,1
Vaccines,Developer,Wuhan Institute of Biological Products/Sinopharm,1
Vaccines,Developer,Bezmialem Vakif University,1
Vaccines,Developer,"Osaka University/ BIKEN/ National Institutes of Biomedical Innovation, Japan",1
Vaccines,Developer,People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech.,1
Vaccines,Developer,DIOSynVax Ltd / University of Cambridge,1
Vaccines,Developer,University of Tokyo/Daiichi-Sankyo,1
Vaccines,Developer,Arcturus/Duke-NUS,1
Vaccines,Developer,Scancell/University of Nottingham/Nottinghar Trent University,1
Vaccines,Developer,University of Alberta,1
Vaccines,Developer,Izmir Biomedicine and Genome Center,1
Vaccines,Developer,"LakePharma, Inc.",1
Vaccines,Developer,Altimmune,1
Vaccines,Developer,"VIDO-InterVac, University of Saskatchewan",1
Vaccines,Developer,Medigen Vaccine Biologics Corporation/NIAID/Dynavax,1
Vaccines,Developer,"West China Hospital, Sichuan University",1
Vaccines,Developer,UW-Madison/FluGen/Bharat Biotech,1
Vaccines,Developer,AJ Vaccines,1
Vaccines,Developer,University of Western Ontario,1
Vaccines,Developer,iBio/cc-Pharming,1
Vaccines,Developer,Translate Bio/Sanofi Pasteur,1
Vaccines,Developer,Aurobindo,1
Vaccines,Developer,AnyGo Technology,1
Vaccines,Developer,Valo Therapeutics Ltd,1
Vaccines,Developer,Clover Biopharmaceuticals Inc./GSK/Dynavax,1
Vaccines,Developer,BioNet Asia,1
Vaccines,Developer,University of Hong Kong,1
Vaccines,Developer,IAVI/Merck,1
Vaccines,Developer,Massachusetts Eye and Ear/Massachusetts General Hospital/AveXis,1
Vaccines,Developer,ExpreS2ion,1
Vaccines,Developer,BiOMVis Sri/Univ. of Trento,1
Vaccines,Developer,Yisheng Biopharma,1
Vaccines,Developer,Israel Institute for Biological Research/Weizmann Institute of Science,1
Vaccines,Developer,Innovax/Xiamen Univ./GSK,1
Vaccines,Developer,Univ. of Pittsburgh,1
Vaccines,Developer,University of Queensland/CSL/Seqirus,1
Vaccines,Developer,Greenlight Biosciences,1
Vaccines,Developer,KU Leuven,1
Vaccines,Developer,Fundacao Oswaldo Cruz and Instituto Buntantan,1
Vaccines,Developer,Lomonosov Moscow State University,1
Vaccines,Developer,Vaxi Bio,1
Vaccines,Developer,Novavax,1
Vaccines,Developer,EpiVax,1
Vaccines,Developer,Entos Pharmaceuticals,1
Vaccines,Developer,Saint-Petersburg scientific research institute of vaccines and serums,1
Vaccines,Developer,Quadram Institute Biosciences,1
Vaccines,Developer,Saiba GmbH,1
Vaccines,Developer,DZIF German Center for Infection Research/IDT Biologika GmbH,1
Vaccines,Developer,Beijing Institute of Biological Products/Sinopharm,1
Vaccines,Developer,Medicago Inc.,1
Vaccines,Developer,Bharat Biotech,1
Vaccines,Developer,CanSino Biological Inc./Beijing Institute of Biotechnology,1
Vaccines,Developer,Chula Vaccine Research Center/University of Pennsylvania,1
Vaccines,Developer,DZIF German Center for Infection Research/CanVirex AG,1
Vaccines,Developer,Moderna/NIAID,1
Vaccines,Developer,Sinovac,1
Vaccines,Developer,GeoVax/BravoVax,1
Vaccines,Developer,IMV Inc,1
Vaccines,Developer,Neovii/Tel Aviv University,1
Vaccines,Developer,"ImmunityBio, Inc. & Nantkwest, Inc.",1
Vaccines,Developer,"Chulalongkorn University/GPO, Thailand",1
Vaccines,Developer,"Navarrabiomed, Oncoimmunology group",1
Vaccines,Developer,"Beijing Minhai Biotechnology Co., Ltd.",1
Vaccines,Developer,CanSino Biologics/Precision NanoSystems,1
Vaccines,Developer,"Kentucky Bioprocessing, Inc",1
Vaccines,Developer,Genexine Consortium,1
Vaccines,Developer,Stabilitech Biopharma Ltd,1
Vaccines,Developer,"National Center for Genetic Engineering and Biotechnology (BIOTEC) /GPO, Thailand",1
Vaccines,Developer,University of Oxford/AstraZeneca,1
Vaccines,Developer,Ege University,1
Vaccines,Developer,Doherty Institute,1
Vaccines,Developer,Takis/Applied DNA Sciences/Evvivax,1
Vaccines,Developer,Inovio Pharmaceuticals/ International Vaccine Institute,1
Vaccines,Developer,OncoGen,1
Vaccines,Developer,Codagenix/Serum Institute of India,1
Vaccines,Developer,Axon Neuroscience SE,1
Vaccines,Developer,"University of San Martin and CONICET, Argentina",1
Vaccines,Developer,Imophoron Ltd and Bristol University's Max Planck Centre,1
Vaccines,Developer,Imperial College London,1
Vaccines,Developer,"The Lancaster University, UK",1
Vaccines,Developer,China CDC/Tongji University/Stermina,1
Vaccines,Developer,Vaxart,1
Vaccines,Developer,Vaxine Pty Ltd/Medytox,1
Vaccines,Platform,Protein Subunit,61
Vaccines,Platform,Non-Replicating Viral Vector,24
Vaccines,Platform,RNA,23
Vaccines,Platform,Replicating Viral Vector,19
Vaccines,Platform,DNA,16
Vaccines,Platform,Inactivated,15
Vaccines,Platform,VLP,13
Vaccines,Platform,Live Attenuated Virus,3
Vaccines,Platform,Replicating Bacteria Vector,1
Vaccines,Candiate Type,Inactivated,9
Vaccines,Candiate Type,mRNA,8
Vaccines,Candiate Type,Peptide,3
Vaccines,Candiate Type,LNP-mRNA,3
Vaccines,Candiate Type,Codon deoptimized live attenuated vaccines,3
Vaccines,Candiate Type,VSV-S,3
Vaccines,Candiate Type,S protein,3
Vaccines,Candiate Type,Protein Subunit,3
Vaccines,Candiate Type,VLP,3
Vaccines,Candiate Type,DNA vaccine,3
Vaccines,Candiate Type,OMV-based vaccine,2
Vaccines,Candiate Type,Recombinant S protein,2
Vaccines,Candiate Type,RBD-based,2
Vaccines,Candiate Type,LNP-encapsulated mRNA,2
Vaccines,Candiate Type,Inactivated + CpG 1018,2
Vaccines,Candiate Type,DNA with electroporation,2
Vaccines,Candiate Type,Measles Vector,2
Vaccines,Candiate Type,Adenovirus Type 5 Vector,1
Vaccines,Candiate Type,Adeno-associated virus vector (AAVCOVID),1
Vaccines,Candiate Type,S protein (baculovirus production),1
Vaccines,Candiate Type,VLPS peptides/whole virus,1
Vaccines,Candiate Type,Spike-based,1
Vaccines,Candiate Type,"Plasmid DNA, Needle-Free Delivery",1
Vaccines,Candiate Type,Adenovirus-based,1
Vaccines,Candiate Type,Oral Vaccine platform,1
Vaccines,Candiate Type,"Measles Virus (S, N targets)",1
Vaccines,Candiate Type,Capsid-like Particle,1
Vaccines,Candiate Type,Recombinant S1-Fc fusion protein,1
Vaccines,Candiate Type,S subunit intranasal liposomal formulation with GLA/3M052 adjs.,1
Vaccines,Candiate Type,parainfluenza virus 5 (PIV5)-based vaccine expressing the spike protein,1
Vaccines,Candiate Type,DNA Vaccine (GX-19),1
Vaccines,Candiate Type,Adjuvanted microsphere peptide,1
Vaccines,Candiate Type,MVA encoded VLP,1
Vaccines,Candiate Type,Recombinant spike protein with AdvaxM adjuvant,1
Vaccines,Candiate Type,S protein integrated in HIV VLPS,1
Vaccines,Candiate Type,LNP-encapsulated mRNA cocktail encoding VLP,1
Vaccines,Candiate Type,DNA,1
Vaccines,Candiate Type,RBD protein fused with Fc of IgG + Adj.,1
Vaccines,Candiate Type,"Virus-like particles, lentivirus and baculovirus vehicles",1
Vaccines,Candiate Type,Drosophila S2 insect cell expression system VLPs,1
Vaccines,Candiate Type,Outer Membrane Vesicle(OMV)-peptide,1
Vaccines,Candiate Type,Full length recombinant SARS CoV-2 glycoprotein nanoparticle vaccine adjuvanted with Matrix M,1
Vaccines,Candiate Type,adenovirus-based NasoVAX expressing SARS2-CoV spike protein,1
Vaccines,Candiate Type,Influenza A H1N1 vector,1
Vaccines,Candiate Type,Recombinant deactivated rabies virus containing S1,1
Vaccines,Candiate Type,adenovirus-based + HLA-matched peptides,1
Vaccines,Candiate Type,Replicating VSV vector-based DC-targeting,1
Vaccines,Candiate Type,LNP-encapsulated mRNA encoding S,1
Vaccines,Candiate Type,DNA plasmid vaccine,1
Vaccines,Candiate Type,gp-96 backbone,1
Vaccines,Candiate Type,Peptide + nove adjuvant,1
Vaccines,Candiate Type,Spike-based (epitope screening),1
Vaccines,Candiate Type,DNA plasmid vaccine + Adjuvant,1
Vaccines,Candiate Type,Dendritic cell-based vaccine,1
Vaccines,Candiate Type,Nanoparticle vaccine,1
Vaccines,Candiate Type,Attenuated Influenza expressing an antigenic portion of the Spike protein,1
Vaccines,Candiate Type,VSV vector,1
Vaccines,Candiate Type,Plant-derived VLP adjuvanted with GSK or Dynavax adjs.,1
Vaccines,Candiate Type,Ora Ad5 S,1
Vaccines,Candiate Type,"Orally delivered, heat stable subunit",1
Vaccines,Candiate Type,"Protein Subunit S,N,M&S1 protein",1
Vaccines,Candiate Type,Ad5 S (GREVAXTM platform),1
Vaccines,Candiate Type,Oral E. coli-based protein expression system of S and N proteins,1
Vaccines,Candiate Type,Plant-based subunit (RBD-Fc + Adjuvant),1
Vaccines,Candiate Type,Inactivated + alum,1
Vaccines,Candiate Type,Native like Trimeric subunit Spike Protein vaccine,1
Vaccines,Candiate Type,structurally modified spherical particles of the tobacco mosaic virus (TMV),1
Vaccines,Candiate Type,Recombinant protein,1
Vaccines,Candiate Type,"S-Protein (Subunit) Adjuvant, E coli based Expression",1
Vaccines,Candiate Type,DNA plasmid vaccine RBD&N,1
Vaccines,Candiate Type,LNP-nCoVsaRNA,1
Vaccines,Candiate Type,VLP-recombinant protein + Adjuvant,1
Vaccines,Candiate Type,"Subunit protein, plant produced",1
Vaccines,Candiate Type,Sendai virus vector,1
Vaccines,Candiate Type,Synthetic Long Peptide Vaccine candidate for S and M proteins,1
Vaccines,Candiate Type,Subunit vaccine,1
Vaccines,Candiate Type,Outer Membrane Vesicle (OMV)-subunit,1
Vaccines,Candiate Type,Molecular clamp stabilized Spike protein with MF59 adjuvant,1
Vaccines,Candiate Type,Recombinant S protein in IC-BEVS,1
Vaccines,Candiate Type,Inactivated Flu-based SARS-CoV2 vaccine Adjuvant,1
Vaccines,Candiate Type,Measles-vector based,1
Vaccines,Candiate Type,Ad26COVS1,1
Vaccines,Candiate Type,TBD,1
Vaccines,Candiate Type,S protein +Adjuvant,1
Vaccines,Candiate Type,ADDomerTM multiepitope display,1
Vaccines,Candiate Type,Avian paramyxovirus vector (APMV),1
Vaccines,Candiate Type,LNP-encapsulated mRNA encoding RBD,1
Vaccines,Candiate Type,"2nd Gen E2b- Ad5 Spike, RBD, Nucleocapsid Subcutaneous&ora",1
Vaccines,Candiate Type,RBD-protein,1
Vaccines,Candiate Type,Self-amplifying RNA,1
Vaccines,Candiate Type,MVA expressing structural proteins,1
Vaccines,Candiate Type,S-2P protein + CpG 1018,1
Vaccines,Candiate Type,3 LNP-mRNAs,1
Vaccines,Candiate Type,MVA-S encoded,1
Vaccines,Candiate Type,"Virus-like particle, based on RBD displayed on virus-like particles",1
Vaccines,Candiate Type,"DNA, engineered vaccine inserts compatible with multiple delivery systems",1
Vaccines,Candiate Type,DNA plasmid vaccine with electroporation,1
Vaccines,Candiate Type,Adjuvanted protein subunit (RBD),1
Vaccines,Candiate Type,Peptides derived from Spike protein,1
Vaccines,Candiate Type,Oral Salmonella enteritidis (3934Vac) based protein expression system of RBD,1
Vaccines,Candiate Type,li-Key peptide,1
Vaccines,Candiate Type,MVA-S,1
Vaccines,Candiate Type,Adjuvanted recombinant protein (RBD-Dimer),1
Vaccines,Candiate Type,Horsepox vector expressing S protein,1
Vaccines,Candiate Type,RBD protein (baculovirus production) + FAR- Squalene adjuvant,1
Vaccines,Candiate Type,Several mRNA candidates,1
Vaccines,Candiate Type,mRNA in an intranasal delivery system,1
Vaccines,Candiate Type,Peptide antigens formulated in LNP,1
Vaccines,Candiate Type,Adeno-based (rAd26-S+rAd5-S),1
Vaccines,Candiate Type,Liposome-encapsulated mRNA,1
Vaccines,Candiate Type,Adeno5-based,1
Vaccines,Candiate Type,COVID-19 XWG-03 truncated S (spike) proteins,1
Vaccines,Candiate Type,M2-deficient single replication (M2SR) influenza vector,1
Vaccines,Candiate Type,RBD (baculovirus production expressed in Sf9 cells),1
Vaccines,Candiate Type,"Recombinant vaccine based on Influenza A virus, for the prevention of COVID-19 (intranasal)",1
Vaccines,Candiate Type,Replication defective Simian Adenovirus (GRAd) encoding S,1
Vaccines,Candiate Type,Whole-Virion Inactivated,1
Vaccines,Candiate Type,Unknown,1
Vaccines,Candiate Type,Replicating Defective SARS-CoV-2 derived RNAs,1
Vaccines,Candiate Type,VLP + Adjuvant,1
Vaccines,Candiate Type,Newcastle disease virus vector (NDV-SARS- CoV-2/Spike),1
Vaccines,Candiate Type,Replication-competent VSV chimeric virus technology (VSVAG) delivering the SARS-CoV- 2 Spike (S) glycoprotein.,1
Vaccines,Candiate Type,bacTRL-Spike,1
Vaccines,Candiate Type,microneedle arrays S1 subunit,1
Vaccines,Candiate Type,Influenza vector expressing RBD,1
Vaccines,Candiate Type,S1 or RBD protein,1
Vaccines,Candiate Type,YF17D Vector,1
Vaccines,Candiate Type,Inactivated whole virus,1
Vaccines,Candiate Type,ChAdox1-S,1
Vaccines,Candiate Type,Protein Subunit EPV-CoV-19,1
Vaccines,Candiate Type,eV/LP,1
Vaccines,Candiate Type,"DNA plasmid vaccine S,S1,S2,RBD &N",1
Vaccines,Candiate Type,MsDNA vaccine,1
Vaccines,Candiate Type,Live vira vectored vaccine based on attenuated influenza virus backbone (intranasal),1
Vaccines,Candiate Type,RBD + Adjuvant,1
Vaccines,Candiate Type,Enveloped Virus-Like Particle (eV/LP),1
Vaccines,Candiate Type,"Recombinant protein, nanoparticles (based on s-protein and other epitopes)",1
Vaccines,Dose Count,TBD,143
Vaccines,Dose Count,2,25
Vaccines,Dose Count,1,4
Vaccines,Dose Count,2 or 3,1
Vaccines,Dose Count,1 or 2,1
Vaccines,Dose Count,3,1
Vaccines,Dose Timing,TBD,148
Vaccines,Dose Timing,"0,28 days",11
Vaccines,Dose Timing,"0,21 days",7
Vaccines,Dose Timing,"0,14 days",3
Vaccines,Dose Timing,"0,14 or 0,21 days",2
Vaccines,Dose Timing,"0,28 or 0,28,56 days",1
Vaccines,Dose Timing,"0,14 or 0,28 days",1
Vaccines,Dose Timing,"0,28,56 days",1
Vaccines,Dose Timing,"0,56 days",1
Vaccines,Route,TBD,142
Vaccines,Route,IM,31
Vaccines,Route,ID,2
Vaccines,Phase 1 Desc,IFV/COR/04,1
Vaccines,Phase 1 Desc,NCTO4449276,1
Vaccines,Phase 1 Desc,NCT04450004,1
Vaccines,Phase 1 Desc,NCT04527575,1
Vaccines,Phase 1 Desc,NCT04436471 NCT04437875,1
Vaccines,Phase 1 Desc,ChiCTR2000034112,1
Vaccines,Phase 1 Desc,NCT04453852,1
Vaccines,Phase 1 Desc,NCT04405908,1
Vaccines,Phase 1 Desc,ISRCTN17072692,1
Vaccines,Phase 1 Desc,NCT04445194,1
Vaccines,Phase 1 Desc,NCT04487210,1
Vaccines,Phase 1 Desc,NCT04528641,1
Vaccines,Phase 1 Desc,ChiCTR2000037518,1
Vaccines,Phase 1 Desc,NCT04497298,1
Vaccines,Phase 1 Desc,NCT04412538,1
Vaccines,Phase 1 Desc,ACTRN12620000674932p,1
Vaccines,Phase 1 Desc,NCT04283461 Interim Report,1
Vaccines,Phase 1 Desc,ChiCTR2000030906 Study Report,1
Vaccines,Phase 1/2 Desc,NCT04447781 NCTO4336410,1
Vaccines,Phase 1/2 Desc,2020-001038-36 ChiCTR2000034825 Study Report,1
Vaccines,Phase 1/2 Desc,NCTO4480957,1
Vaccines,Phase 1/2 Desc,NCT04436276,1
Vaccines,Phase 1/2 Desc,NCT04471519,1
Vaccines,Phase 1/2 Desc,NCT04473690,1
Vaccines,Phase 1/2 Desc,NCTO4383574 NCTO4352608,1
Vaccines,Phase 1/2 Desc,CTRI/2020/07/026352,1
Vaccines,Phase 1/2 Desc,NCT04530357,1
Vaccines,Phase 1/2 Desc,ChiCTR2000032459,1
Vaccines,Phase 1/2 Desc,PACTR202006922165132 2020-001072-15 Interim Report,1
Vaccines,Phase 1/2 Desc,NCT04470609,1
Vaccines,Phase 1/2 Desc,ChiCTR2000031809 Interim Report,1
Vaccines,Phase 1/2 Desc,NCT04445389,1
Vaccines,Phase 1/2 Desc,NCT04368988,1
Vaccines,Phase 1/2 Desc,NCT04463472 NCT04527081,1
Vaccines,Phase 2 Desc,NCT04515147,1
Vaccines,Phase 2 Desc,NCT04466085,1
Vaccines,Phase 2 Desc,2020-001228-32,1
Vaccines,Phase 2 Desc,ChiCTR2000031781 Study Report,1
Vaccines,Phase 2 Desc,NCT04405076,1
Vaccines,Phase 3 Desc,ChiCTR2000034780,2
Vaccines,Phase 3 Desc,NCT04368728,1
Vaccines,Phase 3 Desc,NCT04530396,1
Vaccines,Phase 3 Desc,NCT04505722 (not yet recruiting),1
Vaccines,Phase 3 Desc,ISRCTN89951424 NCT04516746,1
Vaccines,Phase 3 Desc,NCT04470427,1
Vaccines,Phase 3 Desc,NCT04456595 669/UN6.KEP/EC/2020,1
Vaccines,Phase 3 Desc,NCT04526990,1
Vaccines,Current Stage,Pre-Clinical,142
Vaccines,Current Stage,Phase 1,12
Vaccines,Current Stage,Phase 1/2,10
Vaccines,Current Stage,Phase 3,9
Vaccines,Current Stage,Phase 2,2
Vaccines,Clinical Stage,Pre-Clinical,142
Vaccines,Clinical Stage,Clinical,33
Vaccines,Coronavirus Target,SARS-CoV2,171
Vaccines,Coronavirus Target,SARS-CoV2 and Sarbeco- Coronaviruses,1
Vaccines,Coronavirus Target,Pan-Corona,1
Vaccines,Coronavirus Target,"SARS-CoV2, SARS-CoV, & MERS-CoV",1
Vaccines,Coronavirus Target,SARS-CoV1 SARS-CoV2,1
Vaccines,Shared Platforms,Influenza,6
Vaccines,Shared Platforms,MERS,4
Vaccines,Shared Platforms,SARS,2
Vaccines,Shared Platforms,"JE, Zika",1
Vaccines,Shared Platforms,Many,1
Vaccines,Shared Platforms,"Ebola, Marburg, Lassa",1
Vaccines,Shared Platforms,"HeV, NiV, EBOV, LASSA, CCHFV, MERS",1
Vaccines,Shared Platforms,"CMV, GBM, Zika",1
Vaccines,Shared Platforms,"HAV, InfA, ZIKV, FMD, SIV, RSV, DENV",1
Vaccines,Shared Platforms,Hepatitis C,1
Vaccines,Shared Platforms,"Influenza, SARS-CoV",1
Vaccines,Shared Platforms,"HIV, MERS",1
Vaccines,Shared Platforms,HPV,1
Vaccines,Shared Platforms,"NSCLC, HIV, malaria, Zika",1
Vaccines,Shared Platforms,H7N9,1
Vaccines,Shared Platforms,"Zika, VZV, HSV-2 and Norovirus",1
Vaccines,Shared Platforms,"Flu A, plague",1
Vaccines,Shared Platforms,malaria,1
Vaccines,Shared Platforms,"Zika, H7N9, CHIKV",1
Vaccines,Shared Platforms,"flu, Chik, Zika, EBOV, LASV, HIV/SIV,Cance",1
Vaccines,Shared Platforms,"LASV, EBOV, MARV, HIV",1
Vaccines,Shared Platforms,"InfA, CHIKV, LASV, NORV; EBOV, RVF, HBV, VEE",1
Vaccines,Shared Platforms,"Smallpox, monkeypox",1
Vaccines,Shared Platforms,"Ebola, Marburg, HIV, Zika, Influenza, HPV therapeutic vaccine, BreastCA vaccine",1
Vaccines,Shared Platforms,"rubella, rotavirus",1
Vaccines,Shared Platforms,Multiple candidates,1
Vaccines,Shared Platforms,"Influenza, HIV, SARS-CoV",1
